The immune system plays a central role not only in fighting infections, but also in many other diseases and medical conditions including cancer. The study of the immune system has led to significant findings in many fields of medicine and biology and has resulted in the discovery of novel and unique substances and reagents that are now widely used for diagnosis, evaluation and therapy of different malignant diseases. The development of prophylactic and therapeutic vaccines, as well as innovative combinatorial immunotherapeutic approaches has substantially decreased mortality and increased life expectancy, improved life expectancy and the well being of the millions of patients.
Leading experts from the scientific and clinical arenas and industry will present about novel findings and developments in the constantly changing area of immunological assays and procedures. They will also discuss recent advances in immunotherapy, as they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories will also be discussed.
Network with colleagues to discuss: An update on state-of-the-art immunomonitoring, Novel strategies to identify and validate biomarkers predictive for clinical efficacy, Novel strategies to identify and clinically develop synergistic combination therapies, and outlook on novel druggable targets for immunotherapy.